A 54-year-old man presents for a routine follow-up 9 months after receiving a deceased-donor renal allograft. His post-transplant course was initially uncomplicated. His current immunosuppressive regimen includes tacrolimus, mycophenolate mofetil, and prednisone. Over the past six weeks, his serum creatinine has steadily increased from a baseline of mg/dL to mg/dL. He reports no fever, dysuria, or gross hematuria. Vital signs are within normal limits. Trough tacrolimus level is ng/mL (target: ng/mL). Urinalysis shows trace protein and WBCs/hpf, with no RBCs or casts. A renal allograft biopsy is performed, and the pathology report is as follows:
Microscopic Description:
- Glomeruli: 18 glomeruli present, 1 globally sclerosed. The remaining glomeruli demonstrate normocellular tufts with patent capillary loops. No crescents or transplant glomerulopathy are identified.
- Tubules and Interstitium: Patchy mononuclear inflammatory infiltrates involve approximately of the sampled cortex. Focally, multiple tubular cross-sections show lymphocytes crossing the tubular basement membrane, with up to 6 lymphocytes per tubular cross-section. Scattered tubular epithelial cells exhibit markedly enlarged nuclei containing homogenous, basophilic, ground-glass intranuclear inclusions that compress host chromatin against the nuclear membrane. No intracytoplasmic inclusions are seen. Isometric vacuolization of the proximal tubular cytoplasm is absent.
- Vessels: Small arteries and arterioles demonstrate mild intimal fibroplasia. No significant nodular arteriolar hyalinosis or endothelialitis is observed.
- Immunofluorescence: Staining for IgG, IgA, IgM, C3, and C1q is negative in the glomeruli. Peritubular capillaries are negative for C4d deposition.
Based on the histopathologic interpretation of this biopsy, which of the following is the most likely diagnosis?
- Polyomavirus-associated nephropathyAnswer
- BAcute T-cell-mediated rejection
- CCytomegalovirus tubulointerstitial nephritis
- DCalcineurin inhibitor nephrotoxicity
- EActive antibody-mediated rejection